HtrA3 is negatively correlated with lymph node metastasis in invasive ductal breast cancer
- 28 June 2013
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 34 (6) , 3611-3617
Abstract
Breast cancer is the most common cancer in women worldwide. Studies have shown that the high temperature requirement factor A3 (HtrA3) is involved in important physiological processes including maintenance of mitochondrial homeostasis, cell death, and cell signaling. HtrA3 is reported to be downregulated in several cancers and has been correlated with advancing cancer stage. We performed a retrospective study using our breast cancer tissue bank to investigate whether the expression of HtrA3 correlated with lymphatic metastasis in breast cancer and whether the expression of HtrA3 was correlated with estrogen receptor (ER) and progesterone receptor (PR) expression in breast cancer. Breast cancer tissues from 156 invasive ductal breast cancer patients with or without lymphatic metastasis were collected and the levels of HtrA3 were measured by immunohistochemistry and western blotting. The expression of HtrA3 was lower in breast cancer. In particular, HtrA3 expression in breast cancer with lymphatic metastasis was lower than that in breast cancer without lymphatic metastasis. In breast cancers with no lymphatic metastasis, the expression of HtrA3 was lower in patients with ER- and PR-positive tumors, but when breast cancers with lymphatic metastasis were analyzed, there was no difference in HtrA3 expression between ER- and PR-positive or ER- and PR-negative tumors. These data suggest that the expression of HtrA3 was negatively correlated with lymphatic metastasis in breast cancer but not correlated with ER and PR positivity or negativity. A better understanding of the mechanism of HtrA3 may provide the basis for future development of a novel therapeutic target in breast cancer.Keywords
This publication has 30 references indexed in Scilit:
- HTRA proteases: regulated proteolysis in protein quality controlNature Reviews Molecular Cell Biology, 2011
- Inhibition of HTRA3 stimulates trophoblast invasion during human placental developmentPlacenta, 2010
- Micrometastases or Isolated Tumor Cells and the Outcome of Breast CancerNew England Journal of Medicine, 2009
- HtrA Serine Proteases as Potential Therapeutic Targets in CancerCurrent Cancer Drug Targets, 2009
- Expression of human HtrA1, HtrA2, HtrA3 and TGF-β1 genes in primary endometrial cancerOncology Reports, 2009
- Overview of Resistance to Systemic Therapy in Patients with Breast Cancer2007
- Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancerGynecologic Oncology, 2006
- Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF‐β signalingDevelopment, Growth & Differentiation, 2004
- Targeting the TGFβ signaling network in human neoplasiaCancer Cell, 2003
- Primary structure of a putative serine protease specific for IGF‐binding proteinsFEBS Letters, 1996